CCO Expert Recap

Lung Cancer Expert Recap

Source: CCO Independent Conference Coverage of the 2009 American Society of Clinical Oncology Annual Meeting*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Lung Cancer Expert Recap

Faculty:

David R. Gandara, MD

CREDIT INFORMATION

Release Date: August 27, 2009

Expiration Date: August 26, 2010

Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Registered Nurses: 0.8 Nursing contact hours

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Evaluate the role of molecular biomarkers in the treatment of patients with non-small-cell lung cancer (NSCLC)
Evaluate new data on novel agents and therapeutic approaches for NSCLC
Employ the integration of new agents and treatment strategies into the clinical management of patients with NSCLC
Evaluate the clinical potential of novel approaches for NSCLC in the maintenance setting

CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.